<DOC>
	<DOCNO>NCT00743834</DOCNO>
	<brief_summary>This study test hypothesis : 1 . 12 week Luvox-CR plus web-based Cognitive-Behavioral Therapy ( CBT ) [ CT-STEPS ] produce great symptom relief OCD treatment Luvox-CR alone ; , 2. subject receive 12 week CT-STEPS add Luvox-CR treatment 12-weeks Luvox-CR monotherapy experience great OCD symptom relief ( week 12-24 ) continue Luvox-CR treatment access CT-STEPS week one . 3. subject begin CT-STEPS week 12 likely complete begin CT-STEPS baseline .</brief_summary>
	<brief_title>Cost-Effectiveness Adding Web-Based Cognitive-Behavioral Therapy ( CBT ) Luvox CR Obsessive Compulsive Disorder ( OCD )</brief_title>
	<detailed_description>Primary Endpoint ( ) : Change Y-BOCS score baseline endpoint week 12 24 ; , number ( percent ) `` responder '' week 12 24 , define subject 35 % decrease Y-BOCS score endpoint Clinical Global Impressions score 1 2 ( much much improve ) . Secondary Endpoint ( ) : 1. change score Work Social Adjustment Scale , quality life measure 2. change score Work Productivity Activity Impairment Questionnaire : Specific Health Problem scale ; particular , analyze change work hours/week lose OCD , change effect OCD work productivity ( 0-10 scale ) . 3. dollar cost per responder 4. dollar cost per total number patient need produce one additional responder Luvox-CR plus web-based CBT group number produce Luvox-CR alone , i.e. , dollar cost per number need treat 5. dollar cost per 5 % decrease Y-BOCS score week 12 24 two treatment group .</detailed_description>
	<mesh_term>Compulsive Personality Disorder</mesh_term>
	<mesh_term>Obsessive-Compulsive Disorder</mesh_term>
	<mesh_term>Compulsive Behavior</mesh_term>
	<mesh_term>Fluvoxamine</mesh_term>
	<criteria>Men woman age 18 year , OCD least 1 year 's duration , meet DSMIV diagnostic criterion , baseline YaleBrown ObsessiveCompulsive Scale ( YBOCS ) score 18 . Pregnant nursing woman woman childbearing age use effective contraceptive method Organic mental disorder Bipolar disorder Psychotic disorder History substance abuse dependence within 3 year evaluation study Major depression suicidal risk Major depression dominate clinical picture Panic disorder Personality disorder severe enough interfere cooperation study procedure Need antipsychotic medication Depot neuroleptic drug within 6 month Fluoxetine within 5 week An MAOI within 2 week , nightly sedative , take medication may interact fluvoxamine Serious unstable medical condition ( hematological , endocrine , cardiovascular , renal gastrointestinal ) , history malignancy ( excise basal cell carcinoma ) , history brain disease , include one childhood febrile convulsion form epilepsy ; , receive behavior therapy OCD . Subjects qualify study take SSRI must take current dose high dose least 12 week prior study baseline . Subjects qualify study take fluvoxamine must take 150 mg/day never trial high dose , must believe investigator able tolerate increase 250 mg/day start baseline , must take prestudy dose high dose ( 150 mg/day ) least 12 week prior study baseline .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2008</verification_date>
</DOC>